Glucosylceramide modulates membrane traffic along the endocytic pathway.
Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a heredita...
Principais autores: | Sillence, D, Puri, V, Marks, D, Butters, T, Dwek, R, Pagano, R, Platt, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registros relacionados
-
Glucosylceramide modulates membrane traffic along the endocytic pathway
por: Dan J. Sillence, et al.
Publicado em: (2002-11-01) -
Glycosphingolipids in endocytic membrane transport.
por: Sillence, D, et al.
Publicado em: (2004) -
Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
por: Norris-Cervetto, E, et al.
Publicado em: (2004) -
The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
por: Smith, D, et al.
Publicado em: (2006) -
Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
por: Walden, C, et al.
Publicado em: (2007)